NASDAQ:TRIB Trinity Biotech Q2 2026 Earnings Results & Report $6.70 +0.67 (+11.01%) As of 01:44 PM Eastern This is a fair market value price provided by Massive. Learn more. Trinity Biotech was expected to report Q2 2026 earnings on September 3, 2026. Analysts expected earnings of -$7.80 per share on revenue of $10.31 million. Confirmed results have not been posted yet. This page will update with the reported figures, conference call transcript, and earnings documents as they become available. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Announcement DateSeptember 3, 2026 Trinity Biotech EPS ResultsActual EPSN/AConsensus EPS -$7.80Beat/MissN/AOne Year Ago EPSN/AEPS Beat Rate3 of last 5 quartersTrinity Biotech Revenue ResultsActual RevenueN/AExpected Revenue$10.31 millionBeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Trinity Biotech Q2 2026 Earnings FAQ When is Trinity Biotech's next earnings date? Trinity Biotech's next earnings date is estimated for Thursday, December 10, 2026. MarketBeat tracks confirmed and estimated earnings dates for Trinity Biotech on the company's earnings history page. Trinity Biotech Earnings HeadlinesCritical Comparison: Trinity Biotech (NASDAQ:TRIB) & Nuwellis (NASDAQ:NUWE)September 28, 2026 | americanbankingnews.comTrinity Biotech Signs Contract With Red Team Investments For AI Data Center Cooling SolutionsSeptember 9, 2026 | rttnews.comPalantir Micron and SanDisk surged before anyone noticedPalantir, Micron, and SanDisk show how fast a stock can move from overlooked to impossible to ignore. A new premium eBook spotlights seven stocks that could be next, before Wall Street crowds in.October 9 at 1:00 AM | StockEarnings (Ad)Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center InfrastructureSeptember 9, 2026 | finance.yahoo.comTrinity Biotech's Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center InfrastructureSeptember 9, 2026 | globenewswire.comTrinity Issues Updates On Diagnostics Launch; Plans To Regain Nasdaq Compliance By Feb '27August 31, 2026 | rttnews.comSee More Trinity Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Trinity Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Trinity Biotech and other key companies, straight to your email. Email Address About Trinity BiotechTrinity Biotech (NASDAQ:TRIB) is a biotechnology and medical diagnostics company headquartered in Bray, Ireland. The company develops, manufactures and markets diagnostic products used by clinical laboratories, healthcare professionals and patients. Its product portfolio includes tests for infectious diseases, autoimmune disorders and diabetes. Trinity Biotech is particularly known for HIV diagnostic products, including rapid and laboratory-based testing solutions, as well as assays and instruments used in clinical testing. The company has also developed products for measuring glycated hemoglobin, an important indicator used in diabetes management. Trinity Biotech serves customers through direct sales and distribution relationships in the United States and international markets, including Europe, Africa and Asia. Its products are used in hospitals, laboratories, physician offices, public-health programs and other healthcare settings. Founded in 1992, Trinity Biotech has expanded its business through internal product development and acquisitions of diagnostic companies and technologies. The company is listed on the Nasdaq Capital Market under the symbol TRIB.View Trinity Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
